Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-026610
Filing Date
2016-08-09
Accepted
2016-08-09 16:45:39
Documents
1
Period of Report
2016-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3924
  Complete submission text file 0000899243-16-026610.txt   5519
Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Abdun-Nabi Daniel (Reporting) CIK: 0001380187 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 161818596

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)